← Back to patent-cliff list
他达拉非/坦洛新
Tier C — Watch / tradeTadalafil/Tamsulosin
Yungjin Pharmaceutical
Originator
2016
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：ADRA1A、PDE5A
Brand：Gugu Tams
Indications (approved)：勃起功能障碍、前列腺增生
Regional status
US
-
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Tadalafil/Tamsulosin?
Approved indications include: 勃起功能障碍, 前列腺增生.
When does the Tadalafil/Tamsulosin patent expire?
No public expiry year is available for Tadalafil/Tamsulosin yet; this page updates once verified.
How do I get a quote for Tadalafil/Tamsulosin intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-24